Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.31%)
As of: Nov 16, 2026 · 12:20 PM EST

Elite Pharmaceuticals (ELTP) Current Assets (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Current Assets of $120.74 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 40.7% from $85.79 million a year earlier and up 5.5% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Current Assets of $112.11 million, up 94.2% from FY2025.

  • Current Assets has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 55.8% (FY2021 to FY2026).
  • By fiscal year, Current Assets came in at $57.74 million in FY2025 (+44.3%), $40.01 million in FY2024 (+86.0%), $21.51 million in FY2023 (+14.0%) and $18.86 million in FY2022 (+54.7%).
  • The fiscal Q2 2027 figure ranks as the highest quarterly Current Assets in data going back to fiscal Q4 2009.
  • Year over year, Current Assets has now increased in each of the last 13 quarters, with growth averaging 65.8% over the last eight quarters.
  • The high point for year-over-year Current Assets in five years was fiscal Q1 2023 (growth of 108.1%); the low point was fiscal Q1 2024 (a decline of 13.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $114.49 million (Q1 2027), $112.11 million (Q4 2026) and $96.79 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,291.18 Bn 1,264.79 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 686.56 Bn 606.42 Bn 17.30 Bn 56.35 Bn
3 AbbVie 525.29 Bn 493.30 Bn 13.12 Bn 37.48 Bn
4 Merck 362.24 Bn 325.18 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 313.66 Bn 286.90 Bn - -
6 Astrazeneca 286.68 Bn 260.20 Bn 13.26 Bn 31.45 Bn
7 Amgen 253.44 Bn 205.10 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 210.62 Bn 185.73 Bn 6.73 Bn 16.55 Bn
9 Pfizer 165.41 Bn 112.77 Bn 12.56 Bn 45.01 Bn
10 Elite Pharmaceuticals 397.46 Mn 270.87 Mn 15.99 Mn 120.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 120.74 Mn
Jun 30, 2026 114.49 Mn
Mar 31, 2026 112.11 Mn
Dec 31, 2025 96.79 Mn
Sep 30, 2025 85.79 Mn
Jun 30, 2025 77.86 Mn
Mar 31, 2025 57.74 Mn
Dec 31, 2024 48.05 Mn
Sep 30, 2024 45.29 Mn
Jun 30, 2024 43.16 Mn
Mar 31, 2024 40.01 Mn
Dec 31, 2023 37.16 Mn
Sep 30, 2023 34.73 Mn
Jun 30, 2023 27.44 Mn
Mar 31, 2023 21.51 Mn
Dec 31, 2022 33.16 Mn
Sep 30, 2022 30.47 Mn
Jun 30, 2022 31.87 Mn
Mar 31, 2022 18.86 Mn
Dec 31, 2021 17.48 Mn
API Access

Elite Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY